Market Tracker

08/30 10:57am ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

3.24
Delayed Data
As of 10:42am ET
 0.00 / 0.00%
Today’s Change
2.44
Today|||52-Week Range
10.60
-62.84%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close3.24
Today’s open3.22
Day’s range3.18 - 3.33
Volume42,582
Average volume (3 months)770,183
Market cap$171.1M
Dividend yield--
Data as of 10:42am ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-44.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd+0.12+1.50%
INNLInnocoll Holdings PL...+0.02+0.36%
ATHXAthersys Inc+0.01+0.51%
STMLStemline Therapeutic...-0.01-0.11%
Data as of 10:41am ET, 08/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts